Hepatitis C News and Research

Latest Hepatitis C News and Research

Virtual clinical trial: Improving methadone dosage for drug users with TB to prevent withdrawal symptoms

Drug users on methadone programs who contract tuberculosis should receive effective treatment while maintaining the correct level of methadone in their bodies, following a virtual clinical trial by pharmacy researchers at Aston University in partnership with drugs charity Addaction.

21 May 2019

New project involves understanding link between opioid crisis and cancer

Jennifer Havens, Ph.D., professor of behavioral science in the University of Kentucky College of Medicine, faculty member in the Center on Drug and Alcohol Research and member of the team awarded $87 million through the National Institutes of Health's HEALing Communities study, has spent the past decade studying the transmission of infectious disease and advocating for the expansion of harm reduction programs.

20 May 2019

Researchers describe the impact of chronic hepatitis D on parts of the immune system

Approximately one out of every ten people with hepatitis B are coinfected with hepatitis D, which is among the most serious liver conditions.

15 May 2019

New findings could facilitate the development of hepatitis C mouse model

Small differences in a liver cell protein have significant impacts on hepatitis C virus replication in mice and humans, findings that could facilitate the development of a mouse model of the infection. The report, led by researchers at Princeton University, was published today in the journal eLife.

12 May 2019

Developing effective needleless vaccine to protect children from dangerous viruses

Millions of people are infected with hepatitis B every year. Hundreds of thousands die. And small children are particularly at risk.

3 May 2019

Study identifies antigens targeted by antibody response to Kawasaki Disease

A new study identifies antigens targeted by the antibody response of children with Kawasaki Disease.

29 Apr 2019

Scientific evidence for and against causal associations for 47 adverse effects after immunization

A new systematic review provides a succinct summary of the scientific evidence for and/or against causal associations for 47 adverse events following immunization.

29 Apr 2019

Researchers examine the barriers to vaccination in immunocompromised children

A new study examines the barriers to vaccination of immunocompromised children. Findings from the study will be presented during the Pediatric Academic Societies 2019 Meeting, taking place on April 24 - May 1 in Baltimore.

27 Apr 2019

Studies verify novel method of HIV transmission among injection drug users and effective prevention

New studies from Lawson Health Research Institute and Western University have found for the first time that HIV can be transmitted through the sharing of equipment used to prepare drugs before injection and that a simple intervention - heating the equipment with a cigarette lighter for 10 seconds - can destroy the HIV virus, preventing that transmission.

26 Apr 2019

Researchers find out barriers to obtaining clean needles and needle exchange

Acute hepatitis C infections rose 98 percent between 2010 and 2015 nationwide, largely because more people were injecting drugs.

26 Apr 2019

Study finds identical alcohol relapse rates among liver transplant recipients regardless of sobriety period

For decades, patients with liver disease related to alcohol use have been told they must be sober for six months before they can get a liver transplant.

26 Apr 2019

Key research takeaways from ECCMID 2019

This article aims to provide a brief overview of the key themes of the 29th ECCMID conference and update readers on current research projects.

From ESCMID 19 Apr 2019

Research sheds light on how hepatitis B virus establishes chronic infection

New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the open-access journal PLOS Pathogens by Haitao Guo of the Indiana University School of Medicine, Bin Wang and Jiming Zhang of Fudan University, and colleagues.

19 Apr 2019

As syphilis invades rural America, a fraying health safety net is failing to stop it

When Karolyn Schrage first heard about the "dominoes gang" in the health clinic she runs in Joplin, Mo., she assumed it had to do with pizza.

19 Apr 2019

Innate immune sensor responding to gut microbes can suppress liver cancer

UT Southwestern researchers have found that a protein in the body's innate immune system that responds to gut microbes can suppress the most common type of liver cancer.

17 Apr 2019

Researchers discover how liver cells protect against viral attacks

Liver cells have an innate resistance to RNA viral infections like hepatitis A, dengue and Zika thanks to a protein called IRF1, according to researchers at the University of North Carolina at Chapel Hill and Tokyo Metropolitan Institute of Medical Science.

16 Apr 2019

New technique uses UV and red light to decontaminate organs before transplantation

A new technique for the decontamination of organs before transplantation using ultraviolet and red light irradiation has been developed by Brazilian and Canadian researchers and is described in an article published in the journal Nature Communications.

12 Apr 2019

New study provides overview of potential risks of vaccinating breastfeeding women

In light of the continuing anti-vaccination movement, a provocative new article provides a comprehensive overview of the potential risks of vaccinating breastfeeding women.

11 Apr 2019

Hepatitis C infections could be reduced by stepping up efforts to prevent transmission in people who inject drugs

Stepping up efforts to prevent transmission of hepatitis C among people who inject drugs, could reduce future infections by 43 per cent globally, according to a study by researchers at the University of Bristol published in the Lancet Gastroenterology and Hepatology today [Tuesday 9 April 2019].

10 Apr 2019

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.

9 Apr 2019

Hepatitis C News and Research

Latest Hepatitis C News and Research

Virtual clinical trial: Improving methadone dosage for drug users with TB to prevent withdrawal symptoms

New project involves understanding link between opioid crisis and cancer

Researchers describe the impact of chronic hepatitis D on parts of the immune system

New findings could facilitate the development of hepatitis C mouse model

Developing effective needleless vaccine to protect children from dangerous viruses

Study identifies antigens targeted by antibody response to Kawasaki Disease

Scientific evidence for and against causal associations for 47 adverse effects after immunization

Researchers examine the barriers to vaccination in immunocompromised children

Studies verify novel method of HIV transmission among injection drug users and effective prevention

Researchers find out barriers to obtaining clean needles and needle exchange

Study finds identical alcohol relapse rates among liver transplant recipients regardless of sobriety period

Key research takeaways from ECCMID 2019

Research sheds light on how hepatitis B virus establishes chronic infection

As syphilis invades rural America, a fraying health safety net is failing to stop it

Innate immune sensor responding to gut microbes can suppress liver cancer

Researchers discover how liver cells protect against viral attacks

New technique uses UV and red light to decontaminate organs before transplantation

New study provides overview of potential risks of vaccinating breastfeeding women

Hepatitis C infections could be reduced by stepping up efforts to prevent transmission in people who inject drugs

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Hepatitis C News and Research

Latest Hepatitis C News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in